Furthermore, curcumin's upregulation of miR‐196b has been associated with suppression of BCR‐ABL expression, enhancing its therapeutic relevance in CML. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.